Synergistic Treatment System for Surgery-Induced Cachexia

A comprehensive system integrating AI, IoT, blockchain, and novel biomaterials to prevent and treat surgery-induced cachexia, enhancing patient outcomes and quality of life.

The original patent addressed the treatment of surgery-induced cachexia using specialized immunonutrition supplements. However, it did not account for the complexity of individual patient responses, limited data tracking, and the potential for more effective treatment combinations. The new inventive concept overcomes these limitations by incorporating cutting-edge technologies to create a personalized, data-driven, and synergistic treatment system.

The system comprises a wearable device for monitoring vital signs, a blockchain-based health record for secure data tracking, and an AI algorithm generating personalized treatment plans. The system administers a specialized immunonutrition supplement, which can be combined with novel biomaterial implants for enhanced wound healing. IoT-enabled sensors monitor and adjust the supplement's delivery in real-time based on the patient's physiological response. A machine learning model predicts patient outcomes, and a user interface provides healthcare providers with data-driven treatment recommendations.

The integration of AI, IoT, blockchain, and novel biomaterials with the original patented concept creates a new, non-obvious synergistic treatment system. The AI-driven analytics and IoT-enabled real-time monitoring introduce a level of personalization and adaptability not present in the original patent.

Alternative embodiments could include the use of different AI algorithms, varying IoT sensor configurations, or the incorporation of additional biomaterials. Variations could involve integrating the system with existing electronic health records or using different types of wearable devices.

The synergistic treatment system has significant commercial potential in the healthcare industry, particularly in the fields of surgical oncology, wound care, and personalized medicine. Target markets include hospitals, clinics, and healthcare providers seeking to improve patient outcomes and reduce treatment costs.